-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on CalciMedica (CALC)
-
-
-
-
-
-
-
CalciMedica (CALC) to Present Late-Breaking Positive Data, Including a Win Ratio Analysis, from Phase 2b CARPO Trial of Auxoraâ„¢ in Acute Pancreatitis (AP) at the American College of Gastroenterology
-
-
-
-
-
-
-
CalciMedica (CALC) PT Lowered to $15 at Jones Trading
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

